Torres Gerard, Sánchez-de-la-Torre Manuel, Barbé Ferran
From the Respiratory Department, Hospital Universitari Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Catalonia.
From the Respiratory Department, Hospital Universitari Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Catalonia; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Chest. 2015 Sep;148(3):824-832. doi: 10.1378/chest.15-0136.
There is a bidirectional association between OSA and systemic hypertension. The strengths of this relationship appear to be modulated by factors such as age, sex, and somnolence. The 24-h BP circadian pattern also appears to be influenced by OSA. Patients with this syndrome exhibit a high prevalence of nondipping or riser circadian patterns, which are related to clinical and subclinical organ damage in the heart and brain. However, the influence of OSA on nocturnal hypertension development has not yet been clarified. A special area of interest is the recognized relationship between OSA and resistant hypertension. The majority of patients with resistant hypertension suffer OSA. CPAP treatment significantly reduces BP in such patients and could play a clinical role in the management of BP in these patients. Several meta-analyses have demonstrated a concordant mild effect of CPAP on systemic hypertension. This effect is related to CPAP compliance, somnolence status, and baseline BP. The effects of oral appliances on BP in patients with OSA must be evaluated in randomized controlled trials. In the absence of additional data reported by clinical studies on other antihypertensive drug treatments, diuretics, particularly antialdosteronic diuretic agents, should be considered the first-line antihypertensive drug treatment in patients with OSA. By reducing parapharyngeal edema and secondary upper airway obstruction, these drugs appear to improve OSA severity and also to reduce BP.
阻塞性睡眠呼吸暂停(OSA)与全身性高血压之间存在双向关联。这种关系的强度似乎受年龄、性别和嗜睡等因素调节。24小时血压昼夜模式似乎也受OSA影响。该综合征患者呈现非勺型或上升型昼夜模式的高患病率,这与心脏和大脑的临床及亚临床器官损害有关。然而,OSA对夜间高血压发展的影响尚未阐明。一个特别受关注的领域是OSA与顽固性高血压之间已被认可的关系。大多数顽固性高血压患者患有OSA。持续气道正压通气(CPAP)治疗可显著降低此类患者的血压,并可能在这些患者的血压管理中发挥临床作用。多项荟萃分析已证明CPAP对全身性高血压有一致的轻度疗效。这种疗效与CPAP依从性、嗜睡状态和基线血压有关。口腔矫治器对OSA患者血压的影响必须在随机对照试验中进行评估。在缺乏临床研究报告的关于其他抗高血压药物治疗的额外数据的情况下,利尿剂,尤其是抗醛固酮利尿剂,应被视为OSA患者的一线抗高血压药物治疗。通过减轻咽旁水肿和继发性上气道阻塞,这些药物似乎可改善OSA严重程度并降低血压。